Stocks
Dicerna Pharmaceuticals (DRNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -19 889% | -2 603% | -1 416% | -498.7% | -67.3% | -61.5% | ||
| Changes by years, y/y, % | +13 970pp | +17 286pp | +1 187pp | +918pp | +431pp | -71.2% | |||
Dicerna Pharmaceuticals. EBITDA margin, %
Dicerna Pharmaceuticals. EBITDA margin, changes, pp
Dicerna Pharmaceuticals (DRNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| EBITDA margin, % | ? | -43.6% | -87.9% | -61.2% | -93.4% | -23.5% | -61.5% | |
| Changes by years, y/y, % | +359pp | +491pp | +11pp | -12pp | +20pp | |||
| Changes by quarters, q/q, % | +38pp | -44pp | +27pp | -32pp | +70pp | |||
